1. Lecture list
2017
Feb - Genotoxicity in the pharmaceutical industry. University of Leiden, Leiden, POT course Mutagenicity and carcinogenicity, 17 February,
2017
2016
Dec - Reproductive hormones and menopause. University College of Middelburg, Middelburg, Guest speaker Bachelor physiology program.
9 December, 2016
May - Reproductive hormones and menopause. University College of Middelburg, Middelburg, Guest speaker Bachelor physiology
program. 9 May, 2016
2015
Dec - Reproductive hormones and menopause. University College of Middelburg, Middelburg, Guest speaker Bachelor physiology program.
15 December, 2015
2014
Dec - Reproductive hormones and menopause. University College of Middelburg, Middelburg, Guest speaker Bachelor physiology program.
9 December, 2014
2013
Feb - Genotoxicity in the pharmaceutical industry. University of Leiden, Leiden, POT course Mutagenicity and carcinogenicity, 8 February,
2013
Mar - Toxicogenomics in the pharmaceutical industry. University of Maastricht, Maastricht, POT course Toxicogenomics, 1 March, 2013
2012
Feb - Genotoxicity in the pharmaceutical industry. University of Leiden, Leiden, POT course Mutagenicity and carcinogenicity, 10 February,
2012
Mar - Toxicogenomics in the pharmaceutical industry. University of Maastricht, Maastricht, POT course Toxicogenomics, 2 March, 2012
Jun - Toxicogenomics within the pharmaceutical industry. General usage and the selection and validation of genotoxic biomarkers.
RIVM, Bilthoven, 28 June 2012.
2011
Jan - Toxicogenomics in the pharmaceutical industry. Radboud University Nijmegen, Nijmegen, POT course Organ toxicity, Toxicogenomic
Course, 12 January, 2011
Jan - High Content Screening on micronuclei and phospholipidosis. 6th
meeting on: Human predictive toxicity and ADME/TOX studies, 27-
28 Januari, 2011, Mondial Research Group, Brussel, Belgium.
Mar - Toxicogenomics in the pharmaceutical industry. University of Maastricht, Maastricht, POT Course Toxicogenomics, 4 March, 2011
Jul - Toxicogenomics in the pharmaceutical industry. 6th
annual conference of SMi on ADMET 6-7 July, 2011, Cornthorpe Tara, London,
United Kingdom.
2010
Jan - High throughput screening analysis for genotoxicity and clastogenicity. 5th
meeting on: Human predictive toxicity and ADME/TOX
studies, 28-29 Januari, 2010, Mondial Research Group, Brussel, Belgium.
Feb - Toxicogenomics in the pharmaceutical industry. Ecotec, 22th and 23th Februari, Malaga, Spain.
Feb - Toxicogenomics in the pharmaceutical industry. University of Maastricht, Maastricht, Toxicogenomic Course, 26 February, 2010
Mar - Analysing in vitro toxicity by high throughput and high content screening. High content analysis. 4th
Annual Meeting. 17th
and 18th
March, Berlin, Germany.
Jun - ADME/TOX meeting, 7th
and 8th
June, Cologne, Germany.
Jul - Segragation of genotoxic compounds. 5th
annual conference of SMi on ADMET 7-8 July, 2010, Crown’s Plaza St. James, London,
United Kingdom.
Aug - SBS Course on High Content screening applications. High content screening for micronuclei testing and phospholipidosis. 31th
August,
Coventry, UK
Sep - Toxicogenomics in the pharmaceutical industry. EEMS, 16th
and 17th
September, Oslo, Norway.
Oct - High throughput screening within the pharmaceutical industry. Luciferase based genotoxicity assays. 14th
and 15th
October,
BDS, Science Park, Amsterdam
2009
Jan - High throughput screening analysis for genotoxicity and clastogenicity. 4rd
meeting on: Human predictive toxicity and
ADME/TOX studies, 22-23 Januari, 2009, Mondial Research Group, Brussel, Belgium.
Feb - Toxicogenomics in the pharmaceutical industry. University of Maastricht, Maastricht, Toxicogenomic Course, 28 February, 2009.
Feb - Identification of Non-Genotoxic Carcinogens with the Arylhydrocarbon receptor (AhR) and the peroxisomal proliferator activating
Receptor α (PPARα). Molecular Conceptor, Case Studies in ADME/TOX predictions. D2.1.1 http://www.drugdesign.com
Jul - High throughput screening for genotoxicity and clastogenicity. 4th
annual conference of SMi on ADMET 1-2 July, 2009, Crown’s Plaza
St. James, London, United Kingdom.
Sep - High throughput screening for genotoxicity and clastogenicity. Society for Medicines Research (SMR), 24th September, National
Heart and Lung Institute, Kensington, London.

2. 2008
Jan - High throughput screening for in vitro toxicity testing: A gradual acceptance of new test methods. 3rd
meeting on: Human
predictive toxicity and ADME/TOX studies, 24-25 Januari, 2008, Mondial Research Group, Brussel, Belgium.
Feb - Toxicogenomics in the pharmaceutical industry. University of Maastricht, Maastricht, Toxicogenomic Course, 29 February, 2008.
Apr - High throughput screening for in vitro toxicity testing. Workshop in vitro toxicity. 2-4 April, 2008, Milano, Italy.
Jul - High throughput screening for in vitro toxicity testing: A gradual acceptance of new test methods. 3rd
annual conference of SMi on
ADMET 2-3 July, 2008 The Hatton, London, United Kingdom.
Sep - High throughput screening for in vitro toxicity testing: Fast genotoxic screening. Ehrlich II, 3-5 Oct, 2008, Gymnasium, Nürnberg,
Germany.
Oct - High throughput screening for in vitro toxicity testing: gradual acceptance. Miptec meeting, satellite seminar of Promega, 14-16 Oct,
2008, Congress centre, Basel, Switserland.
Nov - High throughput screening analysis for genotoxicity and clastogenicity. Cell-Based assays, SMi group, 19-20 Nov 2008, Crown Plaza –
St. James, London, United Kingdom.
2007
Jan - High throughput screening for in vitro toxicity testing. Predictive ADME/TOX meeting Mondial Research Group, Brussel, Belgium.
Feb - Promega Seminar, High throughput screening for in vitro toxicity testing. Utrecht, TheNetherlands.
Mar - Validation methods of cellular assays for screening. Hogeschool Breda, Breda, The Netherlands.
Jun - Exploration of toxicity outcome measures. High content analysis, Vienna, Austria.
Sep - High throughput screening for in vitro toxicity testing. SCTT congress, Salzau, Germany.
Nov - High throughput screening for in vitro toxicity testing. Rikilt, Wageningen, The Netherlands.
2006
Mar - Toxicogenomics course. University of Maastricht, Maastricht, The Netherlands.
Sep - High throughput screening for in vitro toxicity testing. Morris, Leuven, Belgium.
2005
Apr - Predictive ADME/Tox congress, High throughput screening for in vitro toxicity testing. London, United Kingdom.
Sep - Promega Seminar, High throughput screening for in vitro toxicity testing. Utrecht, The Netherlands.
Nov - High throughput screening for in vitro toxicity testing. Genotoxocity symposium, Oss, The Netherlands.
2004
Apr - Predictive ADME/Tox congress, High throughput screening for in vitro toxicity testing. Berlin, Germany.
May - Devgen, High throughput screening for in vitro toxicicity testing. Ghent, Belgium.
Nov - Bioanale, Toxicogenomics and pharmaceutical industry. Maastricht, The Netherlands.
2003
Nov - Biodetection systems, High throughput screening for in vitro toxicity testing. Amsterdam, The Netherlands.
1999
Feb - Schoonen W.G.E.J., Vermeulen, G.J., Deckers, G.H., Verbost, P.M. and Kloosterboer, H.J. (1999): Antiprogestins: mechanism of action
and in vitro and in vivo selection. Doorwerth (lecture), Febr . The Netherlands. NVE, Dutch society for endocrinology. Antiprogestins:
mechanism of action and in vitro / in vivo selection.
May - Packard users meeting, Development of in vitro bioassays for high throughput screening of steroid receptors. London, United
Kingdom.
Sep - Schoonen W.G.E.J., Vermeulen, G.J., Deckers, G.H., Verbost, P.M. and Kloosterboer, H.J. (1999): Antiprogestins: mechanism of action
and in vitro and in vivo selection. Sixth International Congress on Hormones and Cancer. Abstract Page 6. Jerusalem, Sept 5-9, Israel.
1998
Apr - Schoonen W.G.E.J. Development of an in vitro assay for progestagenic activity based on stably transfected CHO cells. Son discussie
groep Farmacochemie, Lunteren, The Netherlands.
May -Packard users meeting, Development of in vitro bioassays for high throughput screening of steroid receptors. London, United
Kingdom.